BUSINESS● LOW2h ago · Oct 29, 2026, 11:59 AM
Merck in charts: Keytruda hits $8.60B, Gardasil bounces back to $1.99B; pharma revenue climbs 4.2% Y/Y; animal health reaches $1.68B
Seeking Alpha Tech · global
Merck's financial report shows Keytruda sales at $8.60 billion and Gardasil bouncing back to $1.99 billion, contributing to a 4.2% year-over-year increase in pharma revenue. The animal health division also achieved $1.68 billion, indicating strong performance across key segments.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS31m agoCactus declares $0.15 dividendSeeking Alpha TechBUSINESS31m agoMorguard Real Estate Investment Trust reports Q3 resultsSeeking Alpha Tech